New hope for type 2 diabetics: Targeting insulin resistance through the immune modulation of stem cells
- 31 December 2011
- journal article
- review article
- Published by Elsevier BV in Autoimmunity Reviews
- Vol. 11 (2), 137-142
- https://doi.org/10.1016/j.autrev.2011.09.003
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Anti-CD3 antibodies for type 1 diabetes: beyond expectationsThe Lancet, 2011
- Arresting type 1 diabetes after diagnosis: GAD is not enoughThe Lancet, 2011
- Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trialThe Lancet, 2011
- Functional Specialization of Interleukin-17 Family MembersImmunity, 2011
- IL-17 in obesity and adipogenesisCytokine & Growth Factor Reviews, 2010
- Human cord blood stem cells and the journey to a cure for type 1 diabetesAutoimmunity Reviews, 2010
- Stem cell approaches for the treatment of type 1 diabetes mellitusTranslational Research, 2010
- Efforts to Prevent and Halt Autoimmune Beta Cell DestructionEndocrinology and Metabolism Clinics of North America, 2010
- New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetesTranslational Research, 2010
- An immune origin of type 2 diabetes?Diabetologia, 2005